William Rosenberg
Overview
Explore the profile of William Rosenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1654
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Etoori D, Simmons R, Desai M, Foster G, Stuart A, Sabin C, et al.
BMC Public Health
. 2024 Sep;
24(1):2427.
PMID: 39243047
Background: Direct acting antivirals (DAAs) for the Hepatitis C virus (HCV) have shifted the World Health Organisation global strategic focus to the elimination of HCV by 2030. In England, the...
2.
Vergis N, Patel V, Bogdanowicz K, Czyzewska-Khan J, Keshinro R, Fiorentino F, et al.
Clin Gastroenterol Hepatol
. 2024 Aug;
PMID: 39181422
Background And Aims: Short-term mortality in alcohol-related hepatitis (AH) is high, and no current therapy results in durable benefit. A role for interleukin (IL)-1β has been demonstrated in the pathogenesis...
3.
Brennan P, Tavabie O, Li W, Marjot T, Corless L, Fallowfield J, et al.
Lancet Gastroenterol Hepatol
. 2024 Mar;
9(6):577-582.
PMID: 38428439
The American, European, and Latin American liver societies have proposed a change in the nomenclature we use to describe alcohol-related liver disease and non-alcoholic fatty liver disease. Additionally, a term...
4.
Subhani M, Dhanda A, Olaru A, Dunford L, Ahmad N, Wragg A, et al.
Lancet Gastroenterol Hepatol
. 2024 Feb;
9(5):400-402.
PMID: 38330981
No abstract available.
5.
Abeysekera K, Srivastava A, Rowe I, Jarvis H, Ryder S, Yeoman A, et al.
Frontline Gastroenterol
. 2023 Oct;
14(6):483-490.
PMID: 37854785
Introduction: The increasing availability of non-invasive tests (NITs) has created the opportunity to explore their use in improving risk stratification of advanced liver disease. The study aimed to determine the...
6.
Potier J, Durham A, Modi R, Rosenberg W, Dash S
J Equine Vet Sci
. 2023 Oct;
131:104937.
PMID: 37816414
Liver disease is common in equine practice, and treatment and prognosis are dependent on histopathologic examination of biopsies. Liver biopsy is invasive and expensive which restricts its use. Serum markers...
7.
Etoori D, Desai M, Mandal S, Rosenberg W, Sabin C
BMC Infect Dis
. 2023 Sep;
23(1):629.
PMID: 37752434
Background: With the advent of direct acting antivirals, the World Health Organisation proposed eliminating Hepatitis C as a public health threat by 2030. To achieve this, countries need to diagnose,...
8.
MacPherson I, Abeysekera K, Harris R, Mansour D, McPherson S, Rowe I, et al.
Frontline Gastroenterol
. 2022 Sep;
13(5):367-373.
PMID: 36051960
Mortality from chronic liver disease (CLD) in the UK has increased by over 400% since 1970, driven by alcohol, non-alcoholic fatty liver disease and hepatitis C virus, the natural histories...
9.
Gardner A, Ma Y, Bacchetti P, Price J, Kuniholm M, French A, et al.
J Infect Dis
. 2022 Aug;
227(11):1274-1281.
PMID: 35951669
Background: The trajectory of liver fibrosis is not well understood in the contemporary era of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) therapy. Methods: We assessed the Enhanced...
10.
Stejskal L, Kalemera M, Lewis C, Palor M, Walker L, Daviter T, et al.
Elife
. 2022 Jul;
11.
PMID: 35796426
E1 and E2 (E1E2), the fusion proteins of Hepatitis C Virus (HCV), are unlike that of any other virus yet described, and the detailed molecular mechanisms of HCV entry/fusion remain...